CeNeRx BioPharma Inc. Report issue

For profit Phase 1 Phase 2
Founded: Cary NC United States (2005)
Status: Defunct (2013)

Organization Overview

First Clinical Trial
2008
NCT00739908
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

cx157 (3 trials)

cxb909 (1 trial)

Drugs in Phase 1 Trials (1)

Pivagabine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 2)

Depressive Disorder, Treatment-Resistant (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 3